Alpine Bank Wealth Management Royalty Pharma PLC Transaction History
Alpine Bank Wealth Management
- $623 Billion
- Q1 2025
A detailed history of Alpine Bank Wealth Management transactions in Royalty Pharma PLC stock. As of the latest transaction made, Alpine Bank Wealth Management holds 82 shares of RPRX stock, worth $2,639. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82
Previous 998
91.78%
Holding current value
$2,639
Previous $28.2 Million
90.96%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
450Shares Held
296MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.27 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$741 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$546 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$455 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...